The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.
Funding Organization:
The US Department of Health and Human Services National Institutes of Health
Funding Category:
HIV/AIDS
Other Health-Related
Support Types:
Discretionary Grants
Locations:
International
Eligible Organizations:
Maximum Amount:
$275,000
Fund ID:
RFA-DA-25-013
Application Due Date:
Subjects:
Clinical Research
Data Analysis
Health Care Planning
HIV
HIV and AIDS Prevention
Research
Audiences:
At Risk Persons
Community Based Organizations
Health Professionals
Health Services Organizations
People who inject drugs
Persons with HIV/AIDS
Researchers
People with substance use disorder
Last Updated: